Last updated: April 24, 2026
Which companies are tied to Flovent Diskus 250 in the U.S. market?
Flovent Diskus 250 is a brand formulation of fluticasone propionate delivered via a dry powder inhaler (DPI) device. The prescribing-label and regulatory packaging for Flovent Diskus identify the market authorization holder and product manufacturer information tied to the marketed dosage form. The commercially documented supply chain therefore splits into two tracks: (1) drug substance and product manufacturing and (2) inhaler device supply/packaging.
Market authorization holder / brand owner (U.S.):
- GlaxoSmithKline (GSK) (brand “Flovent Diskus”)
Manufacturer / labeler and marketed product manufacturing (U.S.):
- GlaxoSmithKline LLC (U.S. labeler/manufacturer information appears on U.S. product labeling for Flovent Diskus products)
What are the most common supplier archetypes for a DPI like Flovent Diskus 250?
For a DPI such as Flovent Diskus, supply commitments generally fall into these categories:
1) Drug product manufacturing (formulation + filling)
- Produces the fluticasone propionate DPI blend in measured-dose units
- Handles aseptic status is typically not required for DPI, but robust particulate handling and blend uniformity controls are required
2) Inhaler device and blister/foil pack system
- Supplies the molded inhaler housing and internal dose-metering components
- Supplies the blister strip or integrated dose reservoir components (if used by the device architecture)
- Manages compatibility and performance validation (emitted dose and fine particle fraction targets)
3) Tertiary packaging and distribution
- Final cartons, leaflets, NDC packaging configuration
- Warehouse distribution and cold-chain is not typical for fluticasone DPI products
What specific supplier entities have documented roles in Flovent Diskus-type inhaler systems?
Flovent Diskus uses a multi-dose DPI platform. For this product family, the supply chain commonly includes:
- Drug manufacturing and packaging: GSK manufacturing sites (labeler/manufacturer listed on FDA labeling)
- Device platform / DPI system supplier: device engineering and manufacturing is typically handled by specialized inhaler-device vendors under contract, with final assembly and product packaging performed by or under the authority of the drug manufacturer/distributor
What can you treat as “hard supplier” vs “device supplier” for procurement planning?
Procurement and contract negotiations typically need two separate vendor lists:
- Hard suppliers (regulatory product accountability):
- GSK as product labeler/manufacturer of record for Flovent Diskus 250 (FDA labeling/labeler data)
- Device suppliers (mechanical platform and internal components):
- Third-party DPI platform and component suppliers used under contractual manufacturing and device supply arrangements for the Diskus platform
What does the FDA labeling imply about who supplies Flovent Diskus 250?
U.S. prescribing information and labeling for Flovent Diskus products identifies GlaxoSmithKline and GlaxoSmithKline LLC in the marketed product documentation. That is the operational starting point for “who supplies” because it defines:
- The company responsible for the marketed product specification and regulatory compliance in the U.S.
- The organization that holds accountable data for device-drug performance as marketed
For “supplier” searches in practice, the labeler/manufacturer of record is the buyer-facing counterparty for:
- authorized manufacturing changes
- supply continuity
- packaging configuration for U.S. NDCs
Key Takeaways
- Flovent Diskus 250 is supplied in the U.S. under GSK (GlaxoSmithKline / GlaxoSmithKline LLC) product labeling and manufacturing responsibility.
- The DPI supply chain splits into drug product manufacturing/filling and device/inhaler platform components, with device work typically handled by specialized inhaler/device suppliers under contract.
- For procurement and supplier mapping, treat GSK as the accountable supplier of record and map device component suppliers through device platform disclosures and contractual manufacturing relationships tied to the Diskus architecture.
FAQs
1) Who is the brand owner of Flovent Diskus 250 in the U.S.?
GSK (GlaxoSmithKline) is the brand owner for Flovent Diskus products.
2) Who is listed as the U.S. labeler/manufacturer of record?
GlaxoSmithKline LLC is the commonly listed labeler/manufacturer entity on U.S. Flovent Diskus product labeling.
3) Does “supplier” for Flovent Diskus mean only the drug manufacturer?
No. DPI products require both drug product manufacturing and inhaler device system/component supply, which are often separate vendor categories.
4) Are inhaler device suppliers publicly identifiable on the same basis as drug manufacturers?
Drug labeler/manufacturer is typically public in FDA labeling. Device component suppliers may not be named on labeling and are usually inferred through device platform procurement and contract manufacturing records.
5) What supplier list should a procurement team build for DPI continuity?
Build two lists: (1) drug product manufacturing/filling (accountable supplier of record) and (2) inhaler device platform/component suppliers supporting Diskus assembly and performance.
References (APA)
[1] U.S. Food and Drug Administration. (n.d.). Flovent Diskus (fluticasone propionate) prescribing information / drug labeling (U.S. product labeling entries). FDA. https://www.accessdata.fda.gov/
[2] DailyMed. (n.d.). Flovent Diskus 250 mcg (fluticasone propionate) inhalation powder: Prescribing information and label details. National Library of Medicine. https://dailymed.nlm.nih.gov/
